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Summary
Objectives: The main objective of this study was to investigate the effects of pneumococcal
hyaluronidase (0.1—10 mg/ml), alone and in combination with pneumolysin (50 and 100 ng/ml),
on human ciliated epithelium.
Methods: Ciliary beat frequency (CBF) and structural integrity of human ciliated respiratory
epithelium in vitro were studied using a phototransistor technique and a visual scoring index,
respectively.
Results: Hyaluronidaseper sedid not affect eitherCBFor the structural integrity of theepithelium.
However, preincubation of the epithelial strips with hyaluronidase (10 mg/ml) for 30 min at 37 8C
significantlypotentiatedpneumolysin-mediatedciliary slowingandepithelial damage.Hyaluronan,
a substrate of hyaluronidase, had noeffects on the ciliated respiratory epithelium in concentrations
up to 100 mg/ml and did not antagonize the injurious effects of pneumolysin on the epithelium.
However, preincubation of the epithelial strips with hyaluronan (100 mg/ml) was associated with
attenuation of the ciliary slowing and epithelial damage induced by incubation of the strips with
hyaluronidase (10 mg/ml) for 30 min at 37 8C followed by addition of pneumolysin (50 ng/ml).
Conclusions: Although having no direct effects alone, hyaluronidase may contribute to pneumo-
lysin-mediated damage and dysfunction to respiratory epithelium, thereby favoring colonization
and subsequently extra-pulmonary dissemination of the pneumococcus.
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Pneumococcal hyaluronidase is a hyaluronate lyase that
degrades primarily hyaluronan (hyaluronic acid) by cleaving
its hexosaminidic linkages,1 but may also cleave other poly-
saccharide components of intercellular ground substance
such as chondroitin or chondroitin sulfates.1 The enzyme
uses a b-elimination mechanism to degrade its substrate(s)
as opposed to other hyaluronidases that often utilize hydro-
lysis.2
The vast majority of pneumococcal clinical isolates pro-
duce hyaluronidase, and it has been suggested that the
enzyme may be an important virulence factor of the pneu-
mococcus, playing a role both in colonization and invasion.3
Evidence for the role of hyaluronidase in the pathogenesis of
pneumococcal infections is based on a number of experi-
mental studies.1,4 For example, in a mouse model of menin-
gitis, using pneumococcal clinical isolates derived from
children with purulent meningitis, one of the most important
factors associated with the development of experimental
meningitis was high hyaluronidase activity,4 suggesting that
hyaluronidase may play a role in bacterial dissemination and
invasion, and in breaching the blood—brain barrier.1,4 Other
investigators have confirmed that hyaluronidase is involved
in the pathogenesis of meningitis in a murine model of
experimental infection and have suggested that this enzyme
facilitates bloodstream invasion after colonization of the
upper respiratory tract by ‘‘loosening the barrier function
of the nasopharyngeal mucosa’’.1 It appears that hyaluroni-
dase may facilitate translocation of organisms from the lung
to the vascular system, while others have noted the impor-
tance of hyaluronidase production among pneumococcal
isolates causing otitis media.5
To our knowledge, no previous studies have addressed
the effects of hyaluronidase on human ciliated epithelium,
although several have documented that pneumolysin, the
thiol-activated protein of the pneumococcus, does cause
slowing of ciliary beating and damage to the epithelium.6
In the current study we have investigated the effects of
hyaluronidase on human ciliated epithelium in vitro, as well
as the effects of prior incubation of epithelium with this
enzyme on pneumolysin-mediated epithelial injury (ciliary
slowing and epithelial damage).
Materials and methods
Toxins, chemicals and reagents
Recombinant pneumolysin and hyaluronidase were expressed
in Escherichia coli and purified from cell extracts as pre-
viously described.7,8 Unless otherwise indicated all other
chemicals and reagents were purchased from the Sigma
Chemical Co., St Louis, MO, USA, while indicator-free Hank’s
balanced salt solution (HBSS) was purchased from Highveld
Biological (Pty) Ltd, Johannesburg, South Africa.
Human nasal epithelium
This study was approved unconditionally by the Human
Research Ethics Committee of the University of the Witwa-
tersrand, Johannesburg, South Africa.Strips of human nasal ciliated epithelium were obtained
by brushing the inferior nasal turbinate of healthy human
volunteers using a 2-mm bronchoscopy cytology brush, and a
single donor was used for each set of experiments, as pre-
viously described.6,9 The strips of epithelium were collected
into HBSS, and the specimen was then divided into the
appropriate number of 2-ml aliquots, and each aliquot was
centrifuged at 150  g for 10 min. Thereafter, the super-
natant of each aliquot was aspirated and replaced by
800 ml of either HBSS alone (control preparation) or HBSS
containing differing combinations of the various test sub-
stances (test preparation). A closed microscope coverslip-
slide preparation was then prepared for each of the speci-
mens, as previously described.6,9 For each experimental
system it was ensured that the pH of the preparations was
at, or close to, 7.4 both at the beginning and at the end of the
experiment.
After coding by an independent observer, the preparations
were inspected in a blinded fashion, initially, and then hourly
for 4 h, using a Leitz orthoplan phase contrast microscope
(Leitz, Germany) fitted with an electronically controlled
warmstage set to 37 8C (Sensicon, LHE Laboratories, UK).
Ciliary beat frequency (CBF) was measured using a photo-
transistor technique, as previously described.10 A total of ten
readings of CBF were obtained from each preparation, from
the same areas, at each time point. The mean CBF was
measured as the mean value of the ten readings at each
time point. Percent ciliary slowing (CS) was calculated by
subtracting the lowest mean test CBF (invariably at the end
of 4 hours) from the mean control CBF at the same time
point, divided by the mean control CBF  100. In addition, at
each of these sites at which CBF was measured, the presence
or absence of epithelial injury or damage (ED) was recorded,
using a visual scoring index, previously described.9 In short,
the presence of disruption of the normal integrity of the
epithelial surface (presence of irregular contour and break-
up of the normally smooth outline) was recorded by the same
investigator as being either absent or present at the same
sites at which the recordings of the CBF were undertaken.
Experimental systems were designed to investigate the
following:1. The effects of hyaluronidase alone (0.1—10 mg/ml) on the
CBF and structural integrity of human ciliated epithelium
by measuring percent ciliary slowing (% CS) and percent
epithelial damage (% ED).2. The effects of preincubation of the epithelial strips with
hyaluronidase (final concentration 10 mg/ml) for 30 min
at 37 8C on the % CS and % ED induced by pneumolysin
(50 ng/ml and 100 ng/ml).3. The effects of preincubation of the epithelial strips with
hyaluronan (final concentration 100 mg/ml) for 30 min at
37 8C on the % CS and % ED induced by pneumolysin
(50 ng/ml) in the presence and absence of hyaluronidase
(10 mg/ml).The concentrations of pneumolysin used in the current
experiments were based on our previous experience with the
effects of this toxin on human ciliated epithelium9 and are
well within the concentrations of pneumolysin that have
been measured in the cerebrospinal fluid (CSF) of patients
with pneumococcal meningitis.11 The concentrations of hya-
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comparable to those used in previous studies.12,13 Those of
hyaluronidase were also based on the following calculations:
we estimated that in the study by Berry and colleagues,14
approximately 11.2 mg of hyaluronidase were produced per
ml of culture and, notwithstanding differences in the various
assays, we calculated that the amounts of hyaluronidase
produced in relationship to pneumolysin were in a ratio of
approximately 100 to 1, which is close to that used in the
current study. In the case of hyaluronan, the concentration
used was the highest concentration that did not appear to
interfere mechanically with the ciliary beating in association
with its high viscosity.
Neutrophils and erythrocytes
These cells were used to investigate the effects of hyalur-
onidase (10 mg/ml) in the presence and absence of pneumo-
lysin on the structural integrity of single cells in suspension,
as opposed to solid tissue (epithelial strips). Influx of extra-
cellular Ca2+ and release of hemoglobin were used to inves-
tigate the effects of the two pneumococcal proteins on the
structural integrity of human neutrophils and erythrocytes,
respectively. Neutrophils were isolated from the blood of
healthy adult human volunteers as previously described,15
and resuspended to a concentration of 1  107/ml in phos-
phate-buffered saline (0.15 M; pH 7.4), while washed ery-
throcytes (5%) were suspended in HBSS.
To measure influx of Ca2+ into neutrophils, the cells
(1  107/ml) were treated with the calcium-sensitive fluor-
escent dye, fura-2/AM for 30 min at 37 8C, followed by
washing. The fura-2-loaded cells were then resuspended in
HBSS and preincubated for 10 min at 37 8C (2  106 cells/ml)
followed by transfer to thermoregulated cuvettes in a Hitachi
650 10S fluorescence spectrophotometer with excitation and
emission wavelengths set at 340 and 500 nm respectively, and
addition 1 min later of either hyaluronidase (10 mg/ml, final)
or pneumolysin at a predetermined concentration of 8.37 ng/
ml. This is a sub-cytolytic concentration of pneumolysin for
neutrophils, which promotes influx of extracellular Ca2+.15Table 1 The effects of incubation with hyaluronidase followed by
ciliary beat frequency (CBF) and percent epithelial damage (% ED
Experimental system
Epithelial strips in HBSS (control)
Epithelial strips exposed to pneumolysin (50 ng/ml)
Epithelial strips exposed to hyaluronidase (10 mg/ml)
followed by pneumolysin (50 ng/ml)
Epithelial strips exposed to pneumolysin (100 ng/ml)
Epithelial strips exposed to hyaluronidase (10 mg/ml)
followed by pneumolysin (100 ng/ml)
a CBF compared to control and % ED compared to control. The p valu
comparisons was applied.
b CBF compared to equivalent experimental systemwithout hyaluronid
for multiple comparisons was applied. The % ED was not significantl
hyaluronidase.
c NS not significant for both CBF and % ED compared to the equivaleWhen the pneumococcal proteins were used in combination,
the cells were pretreated with hyaluronidase for 10 min at
37 8C, followed by addition of pneumolysin.
In the hemolysis system, hyaluronidase (10 mg/ml) or
pneumolysin (4.8 and 8.37 ng/ml) were added to erythro-
cytes (0.5%, final), which had been preincubated for 10 min
at 37 8C. The cells were then incubated for 30 min at 37 8C
after which intact cells and cell debris were pelleted by
centrifugation and hemoglobin in the supernatants assayed
spectrophotometrically at 405 nm. In combination experi-
ments, the cells were pretreated with hyaluronidase for
10 min at 37 8C followed by addition of pneumolysin.
These systems (influx of Ca2+ into neutrophils and hemo-
lysis) were also used to investigate the effects of hyaluronan
(100 mg/ml) on the pore-forming actions of pneumolysin.
Statistical analysis
Each of the series of experiments on the ciliated epithelium
was repeated a minimum of six times, unless otherwise
indicated. All data were recorded as the mean and standard
deviation (SD). The ciliary beat frequency, % CS and % EDwere
compared in control and test preparations using the Mann—
Whitney U-test (two-tailed). A p value of <0.05 was con-
sidered to be significant.
Results
Effects of hyaluronidase alone on human ciliated epithe-
lium (n = 2)
At concentrations between 0.1 and 10 mg/ml, hyaluroni-
dase alone had no effect on human ciliated epithelium over
4 h in vitro. There was no change in ciliary beat frequency nor
any evidence of epithelial disruption (ED) (mean CBF of
control epithelial strips 11.7  0.82 Hz, no ED; mean CBF
of strips exposed to 0.1 mg/ml of hyaluronidase
11.6  0.70 Hz, no ED; mean CBF of strips exposed to
1 mg/ml of hyaluronidase 11.1  0.74 Hz, no ED; mean CBF
of strips exposed to 10 mg/ml of hyaluronidase
11.5  0.71 Hz, no ED).pneumolysin on human ciliated epithelium in vitro, measuring
)
CBF (Hz) % ED Significance
11.2  0.24 0% —
9.9  0.78 22% <0.005a
8.5  0.69 32% <0.005a
<0.005b
8.5  0.44 28% <0.005a
7.5  1.01 42% <0.005a
NSc
es remained significant when a Bonferroni correction for multiple
ase. The p values remained significantwhen a Bonferroni correction
y different when compared to the experimental system without
nt experimental system without hyaluronidase.
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with hyaluronidase on the ciliary beat frequency
and epithelial damage induced by pneumolysin
(n = 6)
Pneumolysin per se at both concentrations used (50 and
100 ng/ml) caused dose-dependent ciliary slowing and
damage to the structural integrity of the epithelial strips
(Table 1). These effects were significantly enhanced by prior
exposure of the epithelial strips to hyaluronidase (10 mg/ml).
Effects of hyaluronan on the ciliary beat
frequency and epithelial damage mediated by
hyaluronidase in combination with pneumolysin
(n = 6)
Preliminary experiments demonstrated that hyaluronan per
se at concentrations of up to 100 mg/ml, and over the time
course of our experiments, had no effect on human ciliated
epithelium (data not shown). As shown in Table 2, prior
incubation of the epithelial strips with hyaluronan partially
attenuated the ciliary slowing and epithelial damage induced
by incubation of the strips with hyaluronidase (10 mg/ml) for
30 min at 37 8C followed by addition of pneumolysin (50 ng/
ml). Importantly, hyaluronan did not antagonize the injurious
effects of pneumolysin per se on the ciliated epithelium (not
shown).
Neutrophils and erythrocytes
Hyaluronidase (10 mg/ml) did not cause influx of Ca2+ into
neutrophils or hemolysis, while pretreatment of neutrophils
and erythrocytes with this enzyme or with hyaluronan did not
alter the sensitivities of these cells to the pore-forming
actions of pneumolysin (not shown).
Discussion
Pneumococcal hyaluronidase has been reported to enhance
the virulence of the pneumococcus by subverting the struc-
tural integrity of epithelial barriers, thereby favoring colo-
nization and dissemination of this microbial pathogen.1,5 In
the current study, we have identified an additional mechan-Table 2 The effects of preincubation of epithelial strips with hyalu
damage (% ED) induced by exposure to hyaluronidase and pneumo
Experimental system
Epithelial strips in HBSS (control)
Epithelial strips exposed to pneumolysin (50 ng/ml)
Epithelial strips exposed to hyaluronidase (10 mg/ml) followed by
pneumolysin (50 ng/ml)
Epithelial strips preincubated with hyaluronan (100 mg/ml) and th
to hyaluronidase (10 mg/ml) followed by pneumolysin (50 ng/m
a CBF and % ED compared to control. The p values remained significant
b CBF compared to equivalent experimental system without hyaluro
multiple comparisons was applied. % ED was not significantly differentism by which hyaluronidase, acting in concert with pneumo-
lysin, compromises epithelial function and structural
integrity.
Pneumolysin, which possesses both cytotoxic and pro-
inflammatory properties,15,16 has well-recognized detrimen-
tal effects on the structure and function of ciliated epithe-
lium.6,9 All of these actions of the toxin, which are secondary
to its pore-forming activities,16 are thought to contribute to
the virulence of the pneumococcus. Our current observations
demonstrate that while hyaluronidase per se has no detect-
able effects on respiratory epithelium, prior treatment of the
ciliated epithelial strips with this enzyme resulted in
increased ciliary dysfunction and epithelial damage on sub-
sequent exposure to pneumolysin. Inclusion of hyaluronan,
which did not affect the pore-forming actions of pneumoly-
sin, partially negated hyaluronidase-mediated sensitization
of the epithelium to the injurious actions of pneumolysin,
implying primary involvement of the enzymatic activity of
hyaluronidase.
These observations are compatible with a mechanism
whereby hyaluronidase, by enzymatically dismantling the
intercellular matrix and/or hydrolysis of hyaluronan in
epithelial lining fluid,12,13 or by some other means, increases
the accessibility of epithelial cells to pneumolysin. In possi-
ble support of this suggestion is a previous study which
documents the ability of hyaluronidase to shift mucus off
epithelia, which represents another mechanism that may
increase access of pneumolysin to the epithelium.17 This
contention is also reinforced by the failure of hyaluronidase
to increase the sensitivity of single-cell suspensions (erythro-
cytes and neutrophils) to pneumolysin.
Interestingly, interactions between hyaluronidase and
pneumolysin as described in the current study, may be a
strategy utilized by the pneumococcus to maximize viru-
lence, as has recently been proposed by Berry and Paton.18
These authors used a series of mutants of the pneumococcus
in which one or more of the genes encoding selected protein
virulence factors had been disabled. Using a murine model of
experimental peritonitis, they observed that inactivation of
pneumolysin production, but not that of hyaluronidase,
resulted in attenuation of pneumococcal virulence, which
was, however, most pronounced following dual knockout of
the genes encoding each of these proteins.18
In conclusion, the current study has identified novel
mechanisms involving interactions between hyaluronidaseronan on the ciliary beat frequency (CBF) and percent epithelial
lysin
CBF (Hz) % ED Significance
11.3  0.26 0% —
10.1  0.29 20% <0.005a
8.2  0.42 40% <0.005a
en exposed
l)
9.1  0.59 32% <0.005a
<0.05b
when a Bonferroni correction for multiple comparisons was applied.
nan. Not significantly different when a Bonferroni correction for
compared to the experimental system without hyaluronan.
Hyaluronidase augments pneumolysin-mediated injury to human ciliated epithelium 15and pneumolysin, which may contribute to the pathogenesis
of invasive pneumococcal disease. Such insights are neces-
sary, not only to enable innovative vaccine design, but also to
facilitate the development of adjunctive strategies to anti-
biotics in severe pneumococcal disease.
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